The Impact of COVID-19 Outbreak On Quality of Life, Seizure
Frequency, Depression, and Anxiety in Patients with Epilepsy:
A Cross-Sectional Study During the Early Period

Gul, Gunay; EREN, FULYA

doi:10.14744/epilepsi.2021.26122

The Impact of COVID-19 Outbreak On Quality of Life, Seizure Frequency, Depression, and Anxiety in Patients with Epilepsy: A Cross-Sectional Study During the Early Period

Fulya EREN, (Sağlık Bilimleri Üniversitesi, Bakırköy Prof. Dr. Mazhar Osman Ruh Sağlığı ve Nöroloji Eğitim ve Araştırma Hastanesi, Nöroloji Anabilim Dalı, İstanbul, Türkiye)

Günay GÜL (Sağlık Bilimleri Üniversitesi, Nöroloji Anabilim Dalı, Bakırköy Prof. Dr. Mazhar Osman Ruh Sağlığı ve Nöroloji Eğitim ve Araştırma Hastanesi, İstanbul, Türkiye)

Epilepsi

1 0

Yıl: 2021 Cilt: 27 Sayı: 4 Sayfa Aralığı: 212 - 220 Metin Dili: İngilizce DOI: 10.14744/epilepsi.2021.26122 İndeks Tarihi: 17-06-2022

The Impact of COVID-19 Outbreak On Quality of Life, Seizure Frequency, Depression, and Anxiety in Patients with Epilepsy: A Cross-Sectional Study During the Early Period

Öz:

Objectives: Epilepsy, according to our current knowledge, does not increase the risk of Coronavirus disease 2019 (COVID-19) infection or the rate of complications related to this infection. However, the COVID-19 pandemic can have adverse effects on patients with epilepsy (PWE) and affect the mental health of the community in general. This study aimed to evaluate the depression and anxiety of epilepsy patients, the effect of the epidemic on the frequency of seizures, and the quality of life of the patients in the past 3 months during the pandemic. Methods: The patients who were referred to an epilepsy outpatient clinic of a tertiary neuropsychiatry center within the past 2 years were retrospectively evaluated. The data regarding the seizures, quality of life, anxiety, and depression were recorded during follow-up or through an online platform. Seizure frequency, frequency change during the pandemic (April 2020 to June 2020), medications, admissions were obtained, and Beck Depression and Anxiety Scale were applied to the patients. The patients’ quality of life was evaluated using the “Quality of Life Scale Short Form-36 (SF-36)” form. Results: One hundred sixty-four patients (77 men, 87 women) included in the study were analyzed. The median overall seizure frequency and seizure frequency during pandemic were 0.2 seizures/month (0–1) and 0 seizures/month (0–0.9), respectively. 125(76.2%) of the patients reported that they had no seizures during that period. No significant difference was found between the frequency of seizures reported by the patients before and during the pandemic period (p=0.12). Only one patient had a PCR confirmed COVID-19 diagnosis, and the other six patients were diagnosed clinically and radiologically. No significant relationship was found between COVID-19 diagnosis and seizure frequency (p=0.671). 105(64.02%) patients were considered to have depressive symptoms with ten or more points according to the Beck Depression Scale. 116 patients (70.7%) were considered to have anxiety symptoms with nine or more points from the Beck Anxiety Scale. Conclusion: This study was conducted to evaluate the seizure frequency, psychiatric status, and quality of life of PWE in April, May, and June 2020 during the first peak of the COVID-19 pandemic in our country while the social restrictions were applied at the highest level. We found that there was no significant increase in the seizure frequency of patients during the pandemic period and depressive symptoms were common in this patient group and affected their quality of life.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Jin H, Hong C, Chen S, Zhou Y, Wang Y, Mao L, et al. Consensus for prevention and management of Coronavirus disease 2019 (COVID-19) for neurologists. Stroke Vasc Neurol 2020;5(2):146– 51.
2. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77(6):683–90.
3. Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020;367(6483):1260–3.
4. Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dube M, et al. Human Coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses 2019;12(1):14.
5. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 2020;11(7):995–8.
6. Baysal-Kirac L, Uysal H. COVID‑19 associate neurological complications. Neurol Sci Neurophysiol 2020;37:1–3.
7. Sadeghmousavi S, Rezaei N. COVID-19 and multiple sclerosis: predisposition and precautions in treatment. SN Compr Clin Med 2020:1–6. doi: 10.1007/s42399-020-00504-9. [Online ahead of print]
8. Chaudhry F, Bulka H, Rathnam AS, Said OM, Lin J, Lorigan H, et al. COVID-19 in multiple sclerosis patients and risk factors for severe infection. J Neurol Sci 2020;418:117147.
9. Kuroda N, Epilepsy and COVID-19: Associations and important considerations. Epilepsy Behav 2020;108:107122.
10. Cabezudo-Garcia P, Ciano-Petersen NL, Mena-Vazquez N, Pons- Pons G, Castro-Sanchez MV, Serrano-Castro PJ. Incidence and case fatality rate of COVID-19 in patients with active epilepsy. Neurology 2020;95(10):e1417–25.
11. Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and Outcomes of 21 critically Ill patients with COVID-19 in Washington state. JAMA 2020;323(16):1612–4.
12. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 2020;94:55–8.
13. Singhi P. Infectious causes of seizures and epilepsy in the developing world. Dev Med Child Neurol 2011;53(7):600–9.
14. Lu L, Xiong W, Liu D, Liu J, Yang D, Li N, et al. New onset acute symptomatic seizure and risk factors in Coronavirus disease 2019: a retrospective multicenter study. Epilepsia 2020;61(6):e49–53.
15. Tombini M, Assenza G, Quintiliani L, Ricci L, Lanzone J, Ulivi M, et al. Depressive symptoms and difficulties in emotion regulation in adult patients with epilepsy: association with quality of life and stigma. Epilepsy Behav 2020;107:107073.
16. Hossain MM, Tasnim S, Sultana A, Faizah F, Mazumder H, Zou L, et al. Epidemiology of mental health problems in COVID-19: a review. F1000Res 2020;9:636.
17. Salari N, Hosseinian-Far A, Jalali R, Vaisi-Raygani A, Rasoulpoor S, Mohammadi M, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Global Health 2020;16(1):57.
18. Asadi-Pooya AA, Simani L, Shahisavandi M, Barzegar Z. COVID-19, de novo seizures, and epilepsy: a systematic review. Neurol Sci 2021;42(2):415–31.
19. Kuroda N. Mental health considerations for patients with epilepsy during COVID-19 crisis. Epilepsy Behav 2020;111:107198.
20. Hao X, Zhou D, Li Z, Zeng G, Hao N, Li E, et al. Severe psychological distress among patients with epilepsy during the COVID-19 outbreak in southwest China. Epilepsia 2020;61(6):1166–73.
21. Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 2020;7(7):611–27.
22. Hisli N. Beck depresyon envaterinin geçerliliği üzerine bir çalişma. Psikol Dergisi 1988;22(6):118–26.
23. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561– 71.
24. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: Psychometric . J Consult Clin Psychol 1988;56(6):893–7.
25. Ulusoy M. Turkish version of the beck anxiety inventory: Psychometric properties. J Cogn Psycother 1998;12(2):163–72.
26. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30(6):473–83.
27. Koçyiğit H, Aydemir Ö, Fişek G, Ölmez N, Memiş A. Kısa form-36 (KF-36)’nın türkçe versiyonunun güvenilirliği ve geçerliliği. İlaç Tedavi Dergisi 1999;12:102–6.
28. Asadi-Pooya AA. Seizures associated with coronavirus infections. Seizure 2020;79:49–52.
29. Elgamasy S, Kamel MG, Ghozy S, Khalil A, Morra ME, Islam SM. First Case of focal epilepsy associated with SARS-Coronavirus- 2. J Med Virol 2020;92(10):2238–42.
30. Hepburn M, Mullaguri N, George P, Hantus S, Punia V, Bhimraj A, et al. Acute symptomatic seizures in critically Ill patients with COVID-19: Is there an association? Neurocrit Care 2021;34(1):139–43.
31. Huang S, Wu C, Jia Y, Li G, Zhu Z, Lu K, et al. COVID-19 outbreak: The impact of stress on seizures in patients with epilepsy. Epilepsia 2020;61(9):1884–93.
32. Scott AJ, Sharpe L, Hunt C, Gandy M. Anxiety and depressive disorders in people with epilepsy: A meta-analysis. Epilepsia 2017;58(6):973–82.
33. Wiglusz MS, Landowski J, Michalak L, Cubala WJ. Reevaluating the prevalence and diagnostic subtypes of depressive disorders in epilepsy. Epilepsy Behav 2015;53:15–9.
34. Bifftu BB, Dachew BA, Tiruneh BT, Tebeje NB. Depression among people with epilepsy in Northwest Ethiopia: A cross-sectional institution based study. BMC Res Notes 2015;8:585.
35. Demir A, Uslu P, Atasayar G, Kılınçel O, Akkaya C, Bora İ. Evaluation of life quality in epilepsy patients and review of psychiatric diagnosis. Epilepsi 2018;24(1):21–6.
36. Doganavsargil-Baysal O, Cinemre B, Senol Y, Barcin E, Gokmen Z. Epilepsy and stigmatization in Turkey. Epilepsy Behav 2017;73:100–5.
37. Wiebe S, Matijevic S, Eliasziw M, Derry PA. Clinically important change in quality of life in epilepsy. J Neurol Neurosurg Psychiatry 2002;73(2):116–20.
38. Aylin A. Quality of life, depression, anxiety and multidimensional perceived social support in patients with epilepsy. Neuropsychiatr Arch 2009;46:91–7.
39. Jacoby A, Baker GA, Steen N, Buck D. The SF-36 as a health status measure for epilepsy: a psychometric assessment. Qual Life Res 1999;8(4):351–64.
40. Tang S, Xiang M, Cheung T, Xiang YT. Mental health and its correlates among children and adolescents during COVID-19 school closure: the importance of parent-child discussion. J Affect Disord 2021;279:353–60.
41. Zhang Y, Ma ZF. Impact of the COVID-19 pandemic on mental health and quality of life among local residents in Liaoning province, China: a cross-sectional study. Int J Environ Res Public Health 2020;17(7):2381.

APA	EREN F, Gul G (2021). The Impact of COVID-19 Outbreak On Quality of Life, Seizure Frequency, Depression, and Anxiety in Patients with Epilepsy: A Cross-Sectional Study During the Early Period. , 212 - 220. 10.14744/epilepsi.2021.26122
Chicago	EREN FULYA,Gul Gunay The Impact of COVID-19 Outbreak On Quality of Life, Seizure Frequency, Depression, and Anxiety in Patients with Epilepsy: A Cross-Sectional Study During the Early Period. (2021): 212 - 220. 10.14744/epilepsi.2021.26122
MLA	EREN FULYA,Gul Gunay The Impact of COVID-19 Outbreak On Quality of Life, Seizure Frequency, Depression, and Anxiety in Patients with Epilepsy: A Cross-Sectional Study During the Early Period. , 2021, ss.212 - 220. 10.14744/epilepsi.2021.26122
AMA	EREN F,Gul G The Impact of COVID-19 Outbreak On Quality of Life, Seizure Frequency, Depression, and Anxiety in Patients with Epilepsy: A Cross-Sectional Study During the Early Period. . 2021; 212 - 220. 10.14744/epilepsi.2021.26122
Vancouver	EREN F,Gul G The Impact of COVID-19 Outbreak On Quality of Life, Seizure Frequency, Depression, and Anxiety in Patients with Epilepsy: A Cross-Sectional Study During the Early Period. . 2021; 212 - 220. 10.14744/epilepsi.2021.26122
IEEE	EREN F,Gul G "The Impact of COVID-19 Outbreak On Quality of Life, Seizure Frequency, Depression, and Anxiety in Patients with Epilepsy: A Cross-Sectional Study During the Early Period." , ss.212 - 220, 2021. 10.14744/epilepsi.2021.26122
ISNAD	EREN, FULYA - Gul, Gunay. "The Impact of COVID-19 Outbreak On Quality of Life, Seizure Frequency, Depression, and Anxiety in Patients with Epilepsy: A Cross-Sectional Study During the Early Period". (2021), 212-220. https://doi.org/10.14744/epilepsi.2021.26122

APA	EREN F, Gul G (2021). The Impact of COVID-19 Outbreak On Quality of Life, Seizure Frequency, Depression, and Anxiety in Patients with Epilepsy: A Cross-Sectional Study During the Early Period. Epilepsi, 27(4), 212 - 220. 10.14744/epilepsi.2021.26122
Chicago	EREN FULYA,Gul Gunay The Impact of COVID-19 Outbreak On Quality of Life, Seizure Frequency, Depression, and Anxiety in Patients with Epilepsy: A Cross-Sectional Study During the Early Period. Epilepsi 27, no.4 (2021): 212 - 220. 10.14744/epilepsi.2021.26122
MLA	EREN FULYA,Gul Gunay The Impact of COVID-19 Outbreak On Quality of Life, Seizure Frequency, Depression, and Anxiety in Patients with Epilepsy: A Cross-Sectional Study During the Early Period. Epilepsi, vol.27, no.4, 2021, ss.212 - 220. 10.14744/epilepsi.2021.26122
AMA	EREN F,Gul G The Impact of COVID-19 Outbreak On Quality of Life, Seizure Frequency, Depression, and Anxiety in Patients with Epilepsy: A Cross-Sectional Study During the Early Period. Epilepsi. 2021; 27(4): 212 - 220. 10.14744/epilepsi.2021.26122
Vancouver	EREN F,Gul G The Impact of COVID-19 Outbreak On Quality of Life, Seizure Frequency, Depression, and Anxiety in Patients with Epilepsy: A Cross-Sectional Study During the Early Period. Epilepsi. 2021; 27(4): 212 - 220. 10.14744/epilepsi.2021.26122
IEEE	EREN F,Gul G "The Impact of COVID-19 Outbreak On Quality of Life, Seizure Frequency, Depression, and Anxiety in Patients with Epilepsy: A Cross-Sectional Study During the Early Period." Epilepsi, 27, ss.212 - 220, 2021. 10.14744/epilepsi.2021.26122
ISNAD	EREN, FULYA - Gul, Gunay. "The Impact of COVID-19 Outbreak On Quality of Life, Seizure Frequency, Depression, and Anxiety in Patients with Epilepsy: A Cross-Sectional Study During the Early Period". Epilepsi 27/4 (2021), 212-220. https://doi.org/10.14744/epilepsi.2021.26122